Novartis Investigative Site

Marousi 15125

0 studies enrolling now · 2 studies all time

What they study most

Heart Failure With Reduced Ejection Fraction (HF-rEF), Neoplasms, Breast

Studies at this site

• Multiple Patient Program to Ensure Access to LCZ696 Treatment to Patients Diagnosed With Heart Failure With Reduced Ejection Fraction (HF-rEF) — NO_LONGER_AVAILABLE
• EAP (Expanded Access Protocol) Of Lapatinib Combined With Capecitabine In Metastatic Breast Cancer — APPROVED_FOR_MARKETING